Novel targeted therapy development in triple-negative breast cancer

被引：0
|
作者：
Ueno, Naoto T. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.05.448
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SY13-4
引用
收藏
页码：S258 / S258
页数：1
相关论文
共 50 条
  • [41] Mitochondrial Metabolism Targeted Nanoplatform for Efficient Triple-Negative Breast Cancer Combination Therapy
    Lu, Lu
    Liu, Genhua
    Lin, Chuanchuan
    Li, Ke
    He, Tingting
    Zhang, Jixi
    Luo, Zhong
    Cai, Kaiyong
    ADVANCED HEALTHCARE MATERIALS, 2021, 10 (20)
  • [42] Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer
    A. Thakkar
    B. Wang
    M. Picon-Ruiz
    P. Buchwald
    Tan A. Ince
    Breast Cancer Research and Treatment, 2016, 157 : 77 - 90
  • [43] Triple-negative breast cancer and basal-like subtype : Pathology and targeted therapy
    Bando, Yoshimi
    Kobayashi, Tomoko
    Miyakami, Yuko
    Sumida, Satoshi
    Kakimoto, Takumi
    Saijo, Yasuyo
    Uehara, Hisanori
    JOURNAL OF MEDICAL INVESTIGATION, 2021, 68 (3-4): : 213 - 219
  • [44] Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer
    Thakkar, A.
    Wang, B.
    Picon-Ruiz, M.
    Buchwald, P.
    Ince, Tan A.
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 157 (01) : 77 - 90
  • [45] Rare oncogenic mutations of predictive markers for targeted therapy in triple-negative breast cancer
    Tobias J. Grob
    Uwe Heilenkötter
    Stefan Geist
    Peter Paluchowski
    Christian Wilke
    Fritz Jaenicke
    Alexander Quaas
    Waldemar Wilczak
    Matthias Choschzick
    Guido Sauter
    Annette Lebeau
    Breast Cancer Research and Treatment, 2012, 134 : 561 - 567
  • [46] Rare oncogenic mutations of predictive markers for targeted therapy in triple-negative breast cancer
    Grob, Tobias J.
    Heilenkoetter, Uwe
    Geist, Stefan
    Paluchowski, Peter
    Wilke, Christian
    Jaenicke, Fritz
    Quaas, Alexander
    Wilczak, Waldemar
    Choschzick, Matthias
    Sauter, Guido
    Lebeau, Annette
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 134 (02) : 561 - 567
  • [47] Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer
    Camorani, Simona
    Passariello, Margherita
    Agnello, Lisa
    Esposito, Silvia
    Collina, Francesca
    Cantile, Monica
    Di Bonito, Maurizio
    Ulasov, Ilya V.
    Fedele, Monica
    Zannetti, Antonella
    De Lorenzo, Claudia
    Cerchia, Laura
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2020, 39 (01)
  • [48] Recent progress in small molecule agents for the targeted therapy of triple-negative breast cancer
    Islam, Rajibul
    Lam, Kok Wai
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 207
  • [49] Advancements in Polymeric Nanocarriers to Mediate Targeted Therapy against Triple-Negative Breast Cancer
    Fatima, Mahak
    Sheikh, Afsana
    Abourehab, Mohammed A. S.
    Kesharwani, Prashant
    PHARMACEUTICS, 2022, 14 (11)
  • [50] Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer
    Simona Camorani
    Margherita Passariello
    Lisa Agnello
    Silvia Esposito
    Francesca Collina
    Monica Cantile
    Maurizio Di Bonito
    Ilya V. Ulasov
    Monica Fedele
    Antonella Zannetti
    Claudia De Lorenzo
    Laura Cerchia
    Journal of Experimental & Clinical Cancer Research, 39
12345